Cyclacel Pharmaceuticals, Inc.
BERKELEY HEIGHTS, NJ · CIK 0001130166 · Biotech · Private
Small molecule therapeutics targeting cell cycle and apoptosis pathways for cancer and other diseases
bgmsglobal.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $36M
- 8 Form D · Mar 2025
- 18 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 1
- 0 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200920112013201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $15,200,226 | |
| Private capital raised | Form D · SEC | $3,036,000 | |
| Private capital raised | Form D · SEC | $7,000,000 | |
| Private capital raised | Form D · SEC | $8,000,000 | |
| Private capital raised | Form D · SEC | $2,062,112 | |
| Private capital raised | Form D · SEC | $25,000,000 | |
| Private capital raised | Form D · SEC | $1,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2296 | FutureDerm Inc. | — | $468K |
| 2297 | SYNDEVRX INC | — | $38M |
| 2298 | Zya, Inc. | — | $37M |
| 2299 | Cyclacel Pharmaceuticals, Inc. | — | $36M |
| 2300 | Retrotope, Inc. | — | $32M |
| 2301 | Basking Biosciences | — | $29M |
| 2302 | GALATEA BIO INC | — | $3.7M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Nicholas BacopoulosDirector
- John BanhamDirector
- Samuel BarkerDirector
- Avraham Ben-TzviDirector
- Judy ChiaoExecutive Officer
- Kwang ChongDirector
- Kenneth FergusonDirector
- Christopher HenneyDirector
- Gregory HradskyDirector
- Mark KirschbaumExecutive Officer
- David LazarExecutive Officer
- Paul McBarronDirector · Executive Officer
- David NatanDirector
- Spiro RombotisDirector · Executive Officer
- Brian SchwartzDirector
- Lloyd SemsDirector
- Kiu SengExecutive Officer
- Robert SpeigelDirector
- Robert SpiegelDirector
- Daniel SpiegelmanDirector
- David U'PrichardDirector
- Karin WalkerDirector
- Datuk Dr. Doris Wong Sing EeExecutive Officer
Patents
- Crystalline Forms Of Pyrimidino Diazepine Derivativeapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.